Astria Therapeutics
ATXS
ATXS
61 hedge funds and large institutions have $326M invested in Astria Therapeutics in 2022 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 27 increasing their positions, 5 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
267% more capital invested
Capital invested by funds: $88.8M → $326M (+$237M)
55.02% more ownership
Funds ownership: 75.49% → 130.51% (+55%)
42% more funds holding
Funds holding: 43 → 61 (+18)
Holders
61
Holding in Top 10
4
Calls
$3.31M
Puts
$321K
Top Buyers
| 1 | +$44.3M | |
| 2 | +$27M | |
| 3 | +$14.7M | |
| 4 |
ACM
Altium Capital Management
New York
|
+$13.6M |
| 5 |
PA
Perceptive Advisors
New York
|
+$13.5M |
Top Sellers
| 1 | -$2.48M | |
| 2 | -$745K | |
| 3 | -$361K | |
| 4 |
AG
Artal Group
Luxembourg
|
-$301K |
| 5 |
AI
ArchPoint Investors
Coral Gables,
Florida
|
-$220K |